Delivery Order SPE2DB20D3103-SPE2DB24FM5M0
- Not listed
- This is a $11,793.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,256,298 units of Ondansetron HCL 4 mg tablets. The order has a completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, with a total ceiling value of $3,608.26 and a period of performance ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 MG Tablet UD 100S. The contract has a firm fixed price of $2,079.74 and a completion date of August 8, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,891.13, is for the supply of 4,567,826,790 units of the medication Ondansetron ODT 4 mg tablet. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $32,410.81 and a completion date of July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 mg tablets. The contract has a firm fixed price of $5,375.00 and runs through January 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as the primary vehicle for providing a comprehensive range...
- This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,564,170,461 units of Ondansetron HCl 4 mg tablets. The $13,718.34 contract is a firm fixed-price delivery order with an ultimate completion date of April 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,204.31 contract is for the delivery of 500 tablets of the prescription medication Ondansetron HCL 4 mg. The contract has a completion date of July 3, 2025 and does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of 4,560,665 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed price of $5,962.99 and a period of performance through April 21, 2023. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,255,117 units of Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $3,609.81 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM5M0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 mg tablets in quantities of 500s. The delivery order, valued at $5,069.46, has a firm fixed price and an ultimate completion date of February 6, 2024. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of the broader pharmaceutical and medical supply procurement activities between AmerisourceBergen and the DLA to meet the healthcare needs of the U.S. military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 2/5/24 |